Last update :
08/05/2024
Antibiotic   Rifampicin  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Eremfat Austria, Germany
Rif Turkey
Rifa Germany
Rifadin Australia, Great Britain, Iran, Ireland, Italy, Netherlands, New Zealand, Sweden, United States of America
Rifadine Belgium, France, Morocco
Rifaldin Iran, Spain
Rifampicin Germany
Rifampicina Argentina, Ecuador
Rifampin United States of America
Rifoldin Austria
Rimactan Switzerland
Rimactane Ireland
Stability of mixtures   Injection   Stability of mixtures : Rifampicin     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polyvinyl chloride Sodium chloride 0,9% 0,1 mg/ml
Injection   Rifampicin   
Injection   Minocycline hydrochloride 0,1 mg/ml
24°C
8 Hour
Not specified 263
Level of evidence B+
Polyvinyl chloride Sodium chloride 0,9% 0,1 mg/ml
Injection   Rifampicin   
Injection   Minocycline hydrochloride 0,1 mg/ml
4°C
72 Hour
Protect from light 263
Level of evidence B+
Polypropylene Sodium chloride 0,9% 2.4 mg/ml
Injection   Rifampicin   
Injection   Tedizolid phosphate 0.8 mg/ml
-25 >> -15°C°
28 Day
Protect from light 4405
Level of evidence B
Polypropylene Sodium chloride 0,9% 2.4 mg/ml
Injection   Rifampicin   
Injection   Tedizolid phosphate 0.8 mg/ml
2-8°C
6 Day
Protect from light 4405
Level of evidence B
Polypropylene Sodium chloride 0,9% 2.4 mg/ml
Injection   Rifampicin   
Injection   Tedizolid phosphate 0.8 mg/ml
23-27°C
7 Hour
Protect from light 4405
Level of evidence B

  Mentions Légales